NCT07090330Phase 2Active not recruiting

ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque Psoriasis

Study sponsor: Oruka Therapeutics, Inc. · ORKA

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-03-25Actual
Enrollment · participants80Estimated
Source updated2026-07-01Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Apr 2026. After: 25 Mar 2026.

Check registry source

· 2 fields changed

Primary completion date changed

Before: Sep 2026. After: Apr 2026.

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source